Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, it has a long track record of bringing innovative treatments to patients worldwide. Headquartered in Aachen, Germany, Grünenthal is an independent, family-owned company with more than 50 years of experience in pain research.
Focus Areas
Notable Investments
